232 results on '"Scearce, Richard"'
Search Results
2. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
3. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
4. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines
5. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.
6. Immune checkpoint modulation enhances HIV-1 antibody induction
7. Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
8. Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection
9. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
10. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
11. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
12. Priming of Anti-Human Immunodeficiency Virus (HIV) CD8 + Cytotoxic T Cells in vivo by Carrier-Free HIV Synthetic Peptides
13. Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved
14. Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
15. High throughput functional analysis of HIV-1 env genes without cloning
16. Expression of the CD7 Ligand K-12 in Human Thymic Epithelial Cells: Regulation by IFN-γ
17. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
18. Mouse and Human Antibodies that Bind HLA-E-Leader Peptide Complexes and Enhance NK Cell Cytotoxicity
19. RAB11FIP5-Deficient Mice Exhibit Cytokine-Related Transcriptomic Signatures
20. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
21. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor
22. Activation-induced deaminase–deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis
23. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
24. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice
25. Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes
26. Increased immunogenicity of HIV envelope subunit complexed with α 2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF
27. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
28. Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
29. Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
30. Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations
31. Comparison of the CD7 (3A1) Group of T Cell Workshop Antibodies
32. HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies
33. Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
34. Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice
35. HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism
36. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques
37. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
38. Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-Chain
39. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
40. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
41. The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes1
42. Production of Monoclonal Antibodies Reacting with the Cytoplasm and Surface of Differentiated Cells
43. [30] Production of monoclonal antibodies reacting with the cytoplasm and surface of differentiated cells
44. Anti-Ebola MAb 17A3 reacts with bovine and human α-2-macroglobulin proteins
45. HIV-1 Envelope gp41 Antibodies Can Originate from Terminal Ileum B Cells that Share Cross-Reactivity with Commensal Bacteria
46. Induction of HIV-1 Broad Neutralizing Antibodies in 2F5 Knock-in Mice: Selection against Membrane Proximal External Region–Associated Autoreactivity Limits T-Dependent Responses
47. Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1
48. Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
49. Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
50. Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.